Gene-specific Therapy

Gene-Specific Therapy is a therapeutic strategy within cystic fibrosis pharmacotherapy that targets the underlying genetic defect by correcting or compensating for the specific mutation in the CFTR gene, distinguishing it from symptomatic or organ-specific treatments.

132

Publications

8.2K

Citations

857

Authors

316

Institutions

Publications per year

2017–2026

30

Authors

857

  1. DJ
    David J. Porteous

    University of Edinburgh, United Kingdom

    4 publications · 107 citations

    4

    h-index

  2. AR
    Adrian R. Krainer

    Cold Spring Harbor Laboratory, United States

    3 publications · 90 citations

    3

    h-index

  3. SG
    Silvia G. Priori

    University of Pavia, Italy

    3 publications · 537 citations

    3

    h-index

  4. YJ
    Young Jin Kim

    Cold Spring Harbor Laboratory, United States

    3 publications · 90 citations

    3

    h-index

  5. LY
    Lucia Yang

    Cold Spring Harbor Laboratory, United States

    3 publications · 90 citations

    3

    h-index

1–5 of 857

Venues

  1. PubMed

    Repository · 15 publications · 916 citations

    14

    h-index

  2. Gene Therapy

    5 publications · 466 citations

    5

    h-index

  3. Human Gene Therapy

    5 publications · 301 citations

    5

    h-index

  4. Molecular Therapy

    4 publications · 271 citations

    4

    h-index

  5. Journal of Cystic Fibrosis

    4 publications · 273 citations

    4

    h-index

1–5